Avrobio Inc (AVRO)
1.51
+0.10
(+7.09%)
USD |
NASDAQ |
May 24, 16:00
1.50
-0.01
(-0.66%)
After-Hours: 20:00
Avrobio Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.15M |
| September 30, 2023 | 1.198M |
| June 30, 2023 | 83.74M |
| March 31, 2023 | -0.008M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.086M |
| June 30, 2022 | -0.149M |
| March 31, 2022 | -0.032M |
| December 31, 2021 | -0.85M |
| September 30, 2021 | -0.267M |
| June 30, 2021 | -1.229M |
| March 31, 2021 | -0.115M |
| December 31, 2020 | -0.081M |
| September 30, 2020 | -0.031M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.488M |
| March 31, 2020 | -0.577M |
| December 31, 2019 | -0.766M |
| September 30, 2019 | -0.078M |
| June 30, 2019 | -0.401M |
| March 31, 2019 | -0.34M |
| December 31, 2018 | -0.234M |
| September 30, 2018 | -1.198M |
| June 30, 2018 | -0.137M |
| March 31, 2018 | -0.263M |
| December 31, 2017 | -0.081M |
| September 30, 2017 | -0.24M |
| June 30, 2017 | -0.007M |
| March 31, 2017 | -0.055M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.229M
Minimum
Jun 2021
83.74M
Maximum
Jun 2023
3.996M
Average
-0.0835M
Median
Cash from Investing (Quarterly) Benchmarks
| Axonics Inc | 138.23M |
| AIM ImmunoTech Inc | -0.158M |
| Perspective Therapeutics Inc | -47.30M |
| Protalix BioTherapeutics Inc | -0.606M |
| Armata Pharmaceuticals Inc | -0.25M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.569M |
| Cash from Financing (Quarterly) | 0.03M |
| Free Cash Flow | -50.48M |
| Free Cash Flow Per Share (Quarterly) | -0.169 |
| Free Cash Flow Yield | -74.87% |